Packs: map each component
List component names, quantities, materials, purposes and configuration differences for first-aid or procedure packs. Separate medical and non-medical components before assessing grouping and scope.
Orthoses: review grouping rationale
Compare anatomical site, purpose, design, materials and risk across models. A similar name or body site alone does not justify one application.
Evidence and labelling consistency
Map performance, biological, sterilisation and packaging evidence to contact type, duration and sterile claims. Reconcile component and pack labels, instructions and supplied configurations.
Separate AR, ARL and MDMA
AR is the local representative role; ARL concerns representative licensing; MDMA concerns device marketing authorisation. Coordinate agreements, licensing and maintenance without treating an AR licence as product approval.
Representative changes and vigilance
Support scope review, handover, changes and renewal arrangements, with regulatory enquiries, complaints and safety-information coordination. Assess handover conditions and previous-representative cooperation first.
Product-specific assessment
Assess rehabilitation, dressings, urine and ostomy products, orthoses, protective products and dental devices against intended purpose and technology rather than assigning risk from the product name alone.
Grouping and documentation are assessed case by case. Existing overseas certificates and reports do not automatically establish SFDA acceptance.